Hiroshi Inooka

612 total citations
15 papers, 376 citations indexed

About

Hiroshi Inooka is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Hiroshi Inooka has authored 15 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Hiroshi Inooka's work include Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (5 papers) and Chemical Synthesis and Analysis (3 papers). Hiroshi Inooka is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (5 papers) and Chemical Synthesis and Analysis (3 papers). Hiroshi Inooka collaborates with scholars based in Japan and United States. Hiroshi Inooka's co-authors include Satoshi Endo, Chieko Kitada, Tetsuya Ohtaki, Eiji Mizuta, Masahiko Fujino, Masahiro Shirakawa, Haruo Onda, Kazuhiro Ogi, Takahisa Ikegami and Masahiko Fujino and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Hiroshi Inooka

15 papers receiving 366 citations

Peers

Countries citing papers authored by Hiroshi Inooka

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Inooka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Inooka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Inooka more than expected).

Fields of papers citing papers by Hiroshi Inooka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Inooka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Inooka. The network helps show where Hiroshi Inooka may publish in the future.

Co-authorship network of co-authors of Hiroshi Inooka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Inooka. A scholar is included among the top collaborators of Hiroshi Inooka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Inooka. Hiroshi Inooka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design 2017 ·Bioorganic & Medicinal Chemistry ·Takeshi Yasui, Takeshi Yamamoto, Nozomu Sakai, (unknown), Takafumi Takai, (unknown), (unknown), Terufumi Takagi, Kotaro Sakamoto, Satoshi Sogabe, Yusuke Kamada, Weston Lane, Gyorgy Snell, Masashi Iwata, (unknown), Hiroshi Inooka, Junichi Sakamoto, (unknown), Yasuhiro Imaeda	21
2	A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects 2017 ·Bioorganic & Medicinal Chemistry ·Hiroshi Inooka, Kotaro Sakamoto, Tokuyuki Shinohara, Yasushi Masuda, Michiko Terada, Satoshi Kumano, Kotaro Yokoyama, Jiro Noguchi, Naoki Nishizawa, Hidenori Kamiguchi, Hisashi Fujita, Taiji Asami, Shiro Takekawa, Tetsuya Ohtaki	16
3	Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries 2017 ·Biochemical and Biophysical Research Communications ·Toshiyuki Ohnishi, Kotaro Sakamoto, Asano Asami-Odaka, (unknown), Ayako Shimizu, Takashi Ito, Taiji Asami, Tetsuya Ohtaki, Hiroshi Inooka	15
4	PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration 2017 ·Peptides ·Yasushi Masuda, Satoshi Kumano, Jiro Noguchi, Kotaro Sakamoto, Hiroshi Inooka, Tetsuya Ohtaki	9
5	Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice 2017 ·British Journal of Pharmacology ·Hiroaki Nagai, (unknown), Kotaro Yokoyama, Tomoko Asakawa, Hisashi Fujita, (unknown), Jiro Noguchi, (unknown), Naoki Nishizawa, (unknown), (unknown), Hiroshi Inooka, Junichi Sakamoto, Tetsuya Ohtaki, Taiji Asami, Shiro Takekawa	18
6	Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology 2017 ·Biochemistry and Biophysics Reports ·Kotaro Sakamoto, (unknown), Yusuke Kamada, Masahiro Oka, Toshiyuki Ohnishi, Masanori Miwa, Taiji Asami, Hiroshi Inooka	7
7	Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide 2017 ·Journal of Medicinal Chemistry ·(unknown), Naoki Nishizawa, (unknown), Hiroaki Nagai, (unknown), Tomoko Asakawa, Hiroshi Inooka, (unknown), Hisashi Fujita, (unknown), Hideki Hirabayashi, Junichi Sakamoto, Tetsuya Ohtaki, Shiro Takekawa, Taiji Asami	14
8	Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display 2016 ·Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Y. Kawata, Yasushi Masuda, T. Umemoto, Takashi Ito, Taiji Asami, Shiro Takekawa, Tetsuya Ohtaki, Hiroshi Inooka	14
9	EU NORMATIVE SANCTIONS ON BURMA/MYANMAR AND THE DPRK : OUT OF THE EFFECTIVE RANGE OF EU DEMOCRACY PROMOTION? 2011 ·Kyushu University Institutional Repository (QIR) (Kyushu University) ·Hiroshi Inooka	2
10	[Conformation of a peptide ligand bound to its G-protein coupled receptor and its implication for ligand transportation]. 2002 ·PubMed ·Hiroshi Inooka, Masahiro Shirakawa	1
11	Conformation of a peptide ligand bound to its G-protein coupled receptor. 2001 ·Nature Structural Biology ·Hiroshi Inooka, Tetsuya Ohtaki, (unknown), Takahisa Ikegami, Satoshi Endo, Chieko Kitada, Kazuhiro Ogi, Haruo Onda, Masahiko Fujino, Masahiro Shirakawa	145
12	Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues. Conformation determined by 1H NMR and CD spectroscopies and distance geometry in 25% methanol solution. 1992 ·PubMed ·Hiroshi Inooka, Satoshi Endo, Chieko Kitada, E. Mizuta, Yoshihisa Fujino	24
13	Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues 1992 ·International journal of peptide & protein research ·Hiroshi Inooka, Satoshi Endo, Chieko Kitada, Eiji Mizuta, Masahiko Fujino	25
14	Conformation in solution of porcine brain natriuretic peptide determined by combined use of nuclear magnetic resonance and distance geometry 1990 ·European Journal of Biochemistry ·Hiroshi Inooka, Takashi Kikuchi, Satoshi Endo, Yoshihiro Ishibashi, Mitsuhiro Wakimasu, Eiji Mizuta	13
15	Solution conformation of endothelin determined by nuclear magnetic resonance and distance geometry 1989 ·FEBS Letters ·Satoshi Endo, Hiroshi Inooka, Yoshihiro Ishibashi, Chieko Kitada, Eiji Mizuta, Masahiko Fujino	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact